German company MECOTEC group partners with Philippine company DMI to provide mobile, hybrid containers for deep-freeze, transport, storage, and distribution of COVID-19 Vaccines in the Philippines
By Alithea De Jesus
Once again, the technological prowess and superiority of Germany prove that they can address even the most complex problem.
As many are bothered with the transportation of vaccines with the capability maintain the needed temperature, the MECOTEC GmbH, a German cooling technology provider, today announced an exclusive distributor partnership with local company Deutsche Motorgeräte Inc (DMI) to provide specialized mobile, hybrid containers customized for the Philippine market.
The MCF8 is a mobile, hybrid container that allows for the proper freezing, transport, storage, and distribution of COVID-19 vaccines to ensure its extensive administration to communities across the Philippines.
“Vaccine manufacturers, governments, hospitals, and local communities are facing significant challenges in transporting, storing, and distribution of the COVID-19 vaccine options due to the requirement of maintaining a constant temperature from -20℃ down to -80℃ in order to retain their effectiveness. Currently, very few options are available to handle the distribution requirements of these vaccines,” said Enrico Klauer CEO of MECOTEC.
“Through our partnership with DMI, we aim to help equip the Philippines with an effective solution that addresses these concerns as the local distribution of COVID-19 vaccines are on the horizon,” he adds.
“The local distribution of these vaccines require a thorough understanding of our geographical complexities. To address the lengthy logistical lead time often associated with transporting goods within our borders, we need a solution that would allow these vaccines to be stored and transported at the required temperature for a longer period of time.” shares Jess Co President of DMI.
“With MECOTEC’s technology, we can efficiently address these concerns, and even reach smaller and more remote communities,” he adds.
Designed to address these challenges, the MCF8 is equipped with the following beneficial features:
The MCF8 will be available starting the first quarter of 2021.
MECOTEC’s Mobile Hybrid Container Solution for transport, storage, and distribution of COVID-19 vaccines
Technical Diagram of the MCF8-20 (20-foot container version)
The MCF8 can be used to transport and store COVID-19 vaccines at low temperatures down to -80℃ and used as a distribution center in an existing facility to administer the dosage to the public